Literature DB >> 3752195

Surgical management of orbital lymphangioma with the carbon dioxide laser.

J S Kennerdell, J C Maroon, J A Garrity, A A Abla.   

Abstract

Lymphangiomas of the ocular adnexa, especially those in the orbit, are difficult to treat because the unencapsulated tumor freely interdigitates with normal orbital tissue, obliterating any potential surgical plane. Because of the hemorrhagic and friable nature of the tumor, conventional surgical techniques are frequently complicated by bleeding. We used the CO2 laser to remove these lesions subtotally by controlled vaporization in six patients (four girls and two boys, 5 to 17 years old). Three pupils remained dilated postoperatively because of damage to the ciliary nerves and symblepharon formation occurred in one case. None of these has produced any symptoms. In one case, however, laser treatment may have produced corneal anesthesia.

Entities:  

Mesh:

Year:  1986        PMID: 3752195     DOI: 10.1016/0002-9394(86)90003-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  7 in total

Review 1.  [Orbital neoplasia. Part I: Introduction, vascular and neurogenic tumors].

Authors:  M P Schittkowski; N Fichter
Journal:  Ophthalmologe       Date:  2012-10       Impact factor: 1.059

2.  Orbital lymphangioma: an analysis of 26 patients.

Authors:  M Tunç; E Sadri; D H Char
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

3.  Resection of an orbital lymphangioma with the aid of an intralesional liquid polymer.

Authors:  Amit D Malhotra; Mona Parikh; Daniel C Garibaldi; Shannath L Merbs; Neil R Miller; Kieran Murphy
Journal:  AJNR Am J Neuroradiol       Date:  2005 Nov-Dec       Impact factor: 3.825

4.  Intracranial vascular anomalies in patients with periorbital lymphatic and lymphaticovenous malformations.

Authors:  A Bisdorff; J B Mulliken; J Carrico; R L Robertson; P E Burrows
Journal:  AJNR Am J Neuroradiol       Date:  2007-02       Impact factor: 3.825

5.  Sclerosing therapy for orbital lymphangioma using sodium tetradecyl sulfate.

Authors:  Anuchit Poonyathalang; Pisit Preechawat; Pakorn Jiarakongmun; Sirintara Pongpech
Journal:  Jpn J Ophthalmol       Date:  2008-09-05       Impact factor: 2.447

6.  Vascular tumors of the orbit.

Authors:  I Günalp; K Gündüz
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

7.  Sclerotherapy for eyelid and anterior orbital venous-lymphatic malformation.

Authors:  Mohammad Etezad Razavi; Mohammad Taher Rajabi; Narges Hassanpoor; S Saeed Mohammadi
Journal:  J Curr Ophthalmol       Date:  2019-01-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.